HomeVenture Capital

Venture Capital

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

Life Sciences Times - October 16, 2026

Venture Capital

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

Life Sciences Times - October 15, 2026

Venture Capital

Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies

Life Sciences Times - October 13, 2026

Venture Capital

Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy

Life Sciences Times - October 5, 2026

Venture Capital

ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies

Life Sciences Times - September 29, 2026

Venture Capital

Oxford Finance Closes Credit Facility with Renalogic

Life Sciences Times - April 8, 2021 0

Venture Capital

David Evans Shaw Invests in Maxwell Biosciences

Life Sciences Times - April 6, 2021 0

Venture Capital

Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing

Life Sciences Times - March 26, 2021 0

Venture Capital

Komodo Health Secures $220M in Funding Led by Tiger Global

Life Sciences Times - March 22, 2021 0

Venture Capital

IDT Acquires Swift Biosciences

Life Sciences Times - March 12, 2021 0

Venture Capital

Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise

Life Sciences Times - February 18, 2021 0

Venture Capital

BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments

Life Sciences Times - February 10, 2021 0

Venture Capital

Flywheel Secures $15M in Series B Funding

Life Sciences Times - February 3, 2021 0

Venture Capital

Oxford Finance Provides $47 Million Credit Facility to Averhealth

Life Sciences Times - February 2, 2021 0

Venture Capital

Scitara Raises $5 Million to Accelerate Digital Transformation of Scientific Laboratories

Life Sciences Times - January 28, 2021 0

Venture Capital

Outcome Capital Advises Evergreen Systems in Its Sale to Sunstone Partners

Life Sciences Times - January 26, 2021 0

Venture Capital

28th Annual Emerald Groundhog Day Investment Forum Goes Virtual as Pandemic Casts a Long Shadow

Life Sciences Times - January 14, 2021 0

1...112113114 115 Page 113 of 115

Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment

October 23, 2026

Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment

October 23, 2026

Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment

October 23, 2026

Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment

October 23, 2026

Venture Capital

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies

Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy

ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies

Most Read

Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment

Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment

Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment

Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment

EDITOR PICKS

eGenesis Names Daniel Leblanc Chief Manufacturing and Supply Officer

Takeda Reports Positive Phase 4 Results for ENTYVIO in Ulcerative Colitis Treatment

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

THIS WEEK'S STORIES

Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment

Greater Boston Urology Welcomes Dr. Michelle Shabo to Expand Patient Care

eGenesis Names Daniel Leblanc Chief Manufacturing and Supply Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US